US economy will shrink $8 trillion because of COVID-19, CBO says

The Congressional Budget Office predicts that financial fallout from the COVID-19 pandemic will slim the U.S. economy by about $8 trillion over the next decade, according to The Washington Post

Advertisement

The projections were outlined in a June 1 letter to Senate leaders. CBO said the U.S. economy will see $7.9 trillion less growth from 2020-30 than was projected in January. The Washington Post said that decrease represents a 3 percent decline in gross domestic product compared to previous estimates. 

The CBO said reduced consumer spending and the closing of several businesses is what will most hamper the U.S. economy. The more than $2 trillion the federal government approved for emergency spending will offset some of the effects, according to the Post.

View the full letter here. Note that while the CBO says “nominal” GDP will fall by $16 trillion over the next decade, “real” GDP will decrease by about $8 trillion. Economists view the “nominal” measure as less significant as it doesn’t include inflation.

More articles on strategy:
Haven lost its CEO, but experts still believe its mission is the best path forward
The toolkit CommonSpirit sent its 137 hospitals for resuming elective surgeries
How to find trustworthy COVID-19 data: 5 observations from Harvard, Beth Israel researchers

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Strategy

Advertisement

Comments are closed.